Half-Year Liquidity Contract Statement for Valerio Therapeutics

Regulatory News:

Valerio Therapeutics S.A. (Euronext Growth Paris: ALVIO)

Under the liquidity contract entered into between Valerio Therapeutics and Kepler Cheuvreux, the following resources appeared on the liquidity account on December 31st 2023:

- 368,174 shares
- € 144,918.05

- Number of executions on buy side on semester: 324
- Number of executions on sell side on semester: 244
- Traded volume on buy side on semester: 304,205 shares for € 69,976.87
- Traded volume on sell side on semester: 223,191 shares for € 56,117.81

As a reminder :

• the following resources appeared on the last half year statement on 30 June 2023 on the liquidity account:

- 287,160 shares
- € 156,554.06

- Number of executions on buy side on semester: 509
- Number of executions on sell side on semester: 492
- Traded volume on buy side on semester: 634,648 shares for € 258,705.74
- Traded volume on sell side on semester: 923,185 shares for € 402,719.91

• the following resources appeared on the liquidity account when the activity started:

- 87,612 shares
- € 196,423.24

The implementation of this report is carried out in accordance with AMF Decision N°2021-01 of June 22nd 2021 renewing the implementation of liquidity contracts for shares as an accepted market practice.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240131554337/en/

The Onxeo Stock at the time of publication of the news with a raise of +3,91 % to 0,133EUR on Lang & Schwarz stock exchange (31. Januar 2024, 18:34 Uhr).